miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
about
Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteinsLoss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cellsThe ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?miRNAs in human cancerThe role of microRNAs in bladder cancerThe role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancerBladder Cancer Stem-Like Cells: Their Origin and Therapeutic PerspectivesMicroRNAs and Growth Factors: An Alliance Propelling Tumor ProgressionEmerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung CancerHow microRNAs influence both hereditary and inflammatory-mediated colon cancersThe Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound HealingSheep, wolf, or werewolf: cancer stem cells and the epithelial-to-mesenchymal transitionMiR-200, a new star miRNA in human cancerClinical and pathological implications of miRNA in bladder cancerThe miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identityZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistanceThe emerging molecular machinery and therapeutic targets of metastasisRegulating miRNA by natural agents as a new strategy for cancer treatmentDietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC InhibitionThe microRNA-200 family: small molecules with novel roles in cancer development, progression and therapyPreliminary Analysis of the Expression of Selected Proangiogenic and Antioxidant Genes and MicroRNAs in Patients with Non-Muscle-Invasive Bladder CancerThe Regulatory Role of MicroRNAs in EMT and CancerLoss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cellmiR-8 modulates cytoskeletal regulators to influence cell survival and epithelial organization in Drosophila wings.Evidence for mesenchymal-like sub-populations within squamous cell carcinomas possessing chemoresistance and phenotypic plasticity.Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levelsModule network inference from a cancer gene expression data set identifies microRNA regulated modulesMicroRNAs as biomarkers associated with bladder cancer.MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathwaySystems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes.Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasisEffects of miRNA-200b on the development of diabetic retinopathy by targeting VEGFA gene.Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancerA ten-microRNA expression signature predicts survival in glioblastomaImplication of microRNAs in drug resistance for designing novel cancer therapyDifferential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme.Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology.Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells
P2860
Q24299613-CCF102C5-E547-4871-97A8-F148F5B5EA45Q24610880-0349405B-2E2D-4330-91A2-17C8229FF8C4Q24617121-6AC5AB4B-2A2B-43B7-9575-DDA79BD0CF04Q24628889-C5A05EC0-0DE9-43F6-B386-CDA34C9D8C85Q26744149-BB9FFB6A-1273-4127-B6E4-720920A034AAQ26770682-A073FAA9-D071-48D8-99AC-AB54399B358DQ26771263-7FAB634E-BD9B-4706-B8FE-02D202BE0F22Q26796592-6108EFB4-1559-43F9-B216-C5EB96EEC5FBQ26798147-149A797D-16D2-4B1D-8E96-53AFC3DA30EDQ26823451-E4B13344-86CA-4AA8-BFAF-D0A235100BF1Q26827627-2594E0E5-FAA7-4A50-BD4C-F982BA52220AQ26864979-D3A44FCC-03E1-4190-9B59-34FBB43F4953Q27004023-D5C24C02-4642-43CC-B0FC-5647F9DE1A64Q27004262-6D037A47-A813-4099-B229-892490C9E776Q27010233-35232B13-1852-4AA4-85CC-BFB9A92F496CQ27015111-8253551E-A7A5-4C23-9AFA-3F27041F3FA2Q27022207-AF07AAE2-66D4-453C-8968-652C530CDF54Q27026972-B6B770C4-BEB9-4EBD-8BC1-7F4D02C9E085Q27026986-51CA8DD9-EC1D-4EB0-B78E-559EB9FB1F3AQ28083742-5D114B67-00EE-4822-855C-F8A9D26CB903Q28390776-0569F27C-CBE6-4282-98DE-15C9CDB7D562Q28391426-CE8EC461-6EF8-41F4-B9D4-9B9E1A794F1FQ28730032-3567B2CB-3CE3-4F94-8025-538FB6F2263CQ30354484-104F4C77-63D8-4B1C-9675-D607A82E090EQ30359720-04263F01-A69F-4EBE-BCA2-3EA1D01BFD02Q30498197-C72D1796-8D7E-466C-B73C-04C32343A981Q30502172-630131AC-1775-4FA1-B1B4-8B0ED0B0F887Q33564117-082551ED-F3F0-42ED-B36D-1A8413F111D5Q33642335-81903ADD-A1F1-412A-B90D-2DC50851A59EQ33733659-15DA3305-62AB-4B93-A98E-2744BF261336Q33795193-3B9608F6-8DCC-40B9-8E7F-95A65B48C657Q33798322-92E999D5-7714-46C2-9EAB-59AF81194E1EQ33833070-B5C24893-7B09-46A7-B435-7CEF7195C7B7Q33838491-627E30BF-B1AA-47E3-A185-051C539590C9Q33869822-A911C35E-A631-4497-9B92-4B2543C004D3Q33903223-D9124CCA-8170-469C-84D6-6466B41667B4Q33911224-9159EA93-E78A-4857-B428-51E392BBA488Q33945781-0FAA0A96-7B75-4679-B825-3D810D4FBFF7Q34039254-A4CC079D-532A-413B-B556-25FD98E3FA62Q34054835-B888A16D-AF5A-49E7-AAD0-F1DD43A2E971
P2860
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
miR-200 expression regulates e ...... rowth factor receptor therapy.
@ast
miR-200 expression regulates e ...... rowth factor receptor therapy.
@en
miR-200 expression regulates e ...... rowth factor receptor therapy.
@nl
type
label
miR-200 expression regulates e ...... rowth factor receptor therapy.
@ast
miR-200 expression regulates e ...... rowth factor receptor therapy.
@en
miR-200 expression regulates e ...... rowth factor receptor therapy.
@nl
prefLabel
miR-200 expression regulates e ...... rowth factor receptor therapy.
@ast
miR-200 expression regulates e ...... rowth factor receptor therapy.
@en
miR-200 expression regulates e ...... rowth factor receptor therapy.
@nl
P2093
P2860
P1476
miR-200 expression regulates e ...... rowth factor receptor therapy.
@en
P2093
Ameeta Arora
Arlene Siefker-Radtke
Colin Dinney
David McConkey
Liana Adam
Menashe Bar-Eli
Meng Zhong
Milena Nicoloso
P2860
P304
P356
10.1158/1078-0432.CCR-08-2245
P407
P577
2009-08-11T00:00:00Z